The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 26, 2023
Filed:
Apr. 19, 2018
Applicant:
Atyr Pharma, Inc., San Diego, CA (US);
Inventors:
John D. Mendlein, Encinitas, CA (US);
Kathleen Ogilvie, San Diego, CA (US);
Assignee:
aTyr Pharma, Inc., San Diego, CA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/385 (2006.01); C07K 16/46 (2006.01); C07K 19/00 (2006.01); C12N 9/00 (2006.01); A61P 11/00 (2006.01); A61P 29/00 (2006.01); A61K 9/48 (2006.01); A61K 9/51 (2006.01); A61K 31/4418 (2006.01); A61K 31/496 (2006.01); A61K 38/53 (2006.01); A61M 5/178 (2006.01);
U.S. Cl.
CPC ...
C12N 9/93 (2013.01); A61K 9/48 (2013.01); A61K 9/5123 (2013.01); A61K 31/4418 (2013.01); A61K 31/496 (2013.01); A61K 38/53 (2013.01); A61P 11/00 (2018.01); A61P 29/00 (2018.01); C12Y 601/01021 (2013.01); A61M 5/178 (2013.01); C07K 2319/30 (2013.01);
Abstract
Provided are therapies, including combination therapies, for the treatment of lung inflammation, including interstitial lung diseases (ILDs), which include the use of at least one histidyl-tRNA synthetase (HRS) polypeptide or an expressible polynucleotide that encodes the HRS polypeptide, alone or in combination with at least one immunomodulatory agent.